ID   CLH1_HUMAN              Reviewed;        1675 AA.
AC   Q00610; D3DU00; Q6N0A0; Q86TF2;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   18-JUN-2025, entry version 236.
DE   RecName: Full=Clathrin heavy chain 1 {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083};
DE   AltName: Full=Clathrin heavy chain on chromosome 17;
DE            Short=CLH-17;
GN   Name=CLTC {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083,
GN   ECO:0000312|HGNC:HGNC:2092}; Synonyms=CLH17, CLTCL2, KIAA0034;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=PNS, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 560-864 (ISOFORMS 1/2).
RC   TISSUE=Colon;
RX   PubMed=1765375; DOI=10.1016/0888-7543(91)90115-u;
RA   Dodge G.R., Kovalszky I., McBride O.W., Yi H.F., Chu M.-L., Saitta B.,
RA   Stokes D.G., Iozzo R.V.;
RT   "Human clathrin heavy chain (CLTC): partial molecular cloning, expression,
RT   and mapping of the gene to human chromosome 17q11-qter.";
RL   Genomics 11:174-178(1991).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-8.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-8; 64-78; 87-96; 164-205; 228-245; 270-278; 298-320;
RP   355-382; 469-481; 507-519; 572-610; 626-638; 799-806; 831-852; 855-865;
RP   882-903; 1011-1037; 1074-1101; 1123-1130; 1166-1179; 1183-1204; 1216-1245;
RP   1312-1326; 1398-1406; 1435-1453; 1482-1498; 1502-1508; 1510-1516 AND
RP   1610-1620, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma, Hepatoma, and Mammary carcinoma;
RA   Bienvenut W.V., Calvo F., Matallanas D., Cooper W.N., Boldt K.,
RA   von Kriegsheim A.F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   INTERACTION WITH HIP1.
RX   PubMed=11532990; DOI=10.1093/hmg/10.17.1807;
RA   Waelter S., Scherzinger E., Hasenbank R., Nordhoff E., Lurz R., Goehler H.,
RA   Gauss C., Sathasivam K., Bates G.P., Lehrach H., Wanker E.E.;
RT   "The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-
RT   binding protein involved in receptor-mediated endocytosis.";
RL   Hum. Mol. Genet. 10:1807-1817(2001).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [10]
RP   INTERACTION WITH ERBB2.
RX   PubMed=16314522; DOI=10.1128/mcb.25.24.11005-11018.2005;
RA   Giri D.K., Ali-Seyed M., Li L.Y., Lee D.F., Ling P., Bartholomeusz G.,
RA   Wang S.C., Hung M.C.;
RT   "Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell
RT   surface receptor.";
RL   Mol. Cell. Biol. 25:11005-11018(2005).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15858577; DOI=10.1038/nature03502;
RA   Royle S.J., Bright N.A., Lagnado L.;
RT   "Clathrin is required for the function of the mitotic spindle.";
RL   Nature 434:1152-1157(2005).
RN   [12]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16968737; DOI=10.1242/jcs.03192;
RA   Royle S.J., Lagnado L.;
RT   "Trimerisation is important for the function of clathrin at the mitotic
RT   spindle.";
RL   J. Cell Sci. 119:4071-4078(2006).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [14]
RP   INTERACTION WITH FKBP6.
RX   PubMed=18529014; DOI=10.1021/bi8001506;
RA   Jarczowski F., Fischer G., Edlich F.;
RT   "FKBP36 forms complexes with clathrin and Hsp72 in spermatocytes.";
RL   Biochemistry 47:6946-6952(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1494, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-634 AND TYR-1477, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-856; LYS-1441 AND LYS-1501, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH ATG16L1.
RX   PubMed=20639872; DOI=10.1038/ncb2078;
RA   Ravikumar B., Moreau K., Jahreiss L., Puri C., Rubinsztein D.C.;
RT   "Plasma membrane contributes to the formation of pre-autophagosomal
RT   structures.";
RL   Nat. Cell Biol. 12:747-757(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=21297582; DOI=10.1038/emboj.2011.15;
RA   Booth D.G., Hood F.E., Prior I.A., Royle S.J.;
RT   "A TACC3/ch-TOG/clathrin complex stabilises kinetochore fibres by inter-
RT   microtubule bridging.";
RL   EMBO J. 30:906-919(2011).
RN   [24]
RP   INTERACTION WITH RFTN1.
RX   PubMed=21266579; DOI=10.1074/jbc.m110.185793;
RA   Watanabe A., Tatematsu M., Saeki K., Shibata S., Shime H., Yoshimura A.,
RA   Obuse C., Seya T., Matsumoto M.;
RT   "Raftlin is involved in the nucleocapture complex to induce poly(I:C)-
RT   mediated TLR3 activation.";
RL   J. Biol. Chem. 286:10702-10711(2011).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   INTERACTION WITH TACC3, SUBCELLULAR LOCATION, AND MUTAGENESIS OF PRO-65;
RP   SER-67; THR-87; GLN-89; LYS-96; LYS-98 AND 480-LYS--VAL-484.
RX   PubMed=23918938; DOI=10.1083/jcb.201211127;
RA   Hood F.E., Williams S.J., Burgess S.G., Richards M.W., Roth D., Straube A.,
RA   Pfuhl M., Bayliss R., Royle S.J.;
RT   "Coordination of adjacent domains mediates TACC3-ch-TOG-clathrin assembly
RT   and mitotic spindle binding.";
RL   J. Cell Biol. 202:463-478(2013).
RN   [28]
RP   FUNCTION OF THE TACC3/CH-TOG/CLATHRIN COMPLEX.
RX   PubMed=23532825; DOI=10.1242/jcs.124834;
RA   Cheeseman L.P., Harry E.F., McAinsh A.D., Prior I.A., Royle S.J.;
RT   "Specific removal of TACC3-ch-TOG-clathrin at metaphase deregulates
RT   kinetochore fiber tension.";
RL   J. Cell Sci. 126:2102-2113(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-394; SER-1229 AND
RP   SER-1494, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394 AND SER-1494, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   INTERACTION WITH TMEM106B.
RX   PubMed=25066864; DOI=10.1016/j.mcn.2014.07.006;
RA   Stagi M., Klein Z.A., Gould T.J., Bewersdorf J., Strittmatter S.M.;
RT   "Lysosome size, motility and stress response regulated by fronto-temporal
RT   dementia modifier TMEM106B.";
RL   Mol. Cell. Neurosci. 61:226-240(2014).
RN   [32]
RP   SUBCELLULAR LOCATION.
RX   PubMed=25596274; DOI=10.1242/bio.201410843;
RA   Gutierrez-Caballero C., Burgess S.G., Bayliss R., Royle S.J.;
RT   "TACC3-ch-TOG track the growing tips of microtubules independently of
RT   clathrin and Aurora-A phosphorylation.";
RL   Biol. Open 4:170-179(2015).
RN   [33]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [34]
RP   INTERACTION WITH RFTN1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=27022195; DOI=10.4049/jimmunol.1501734;
RA   Tatematsu M., Yoshida R., Morioka Y., Ishii N., Funami K., Watanabe A.,
RA   Saeki K., Seya T., Matsumoto M.;
RT   "Raftlin controls lipopolysaccharide-induced TLR4 internalization and
RT   TICAM-1 signaling in a cell type-specific manner.";
RL   J. Immunol. 196:3865-3876(2016).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 1-364 IN COMPLEX WITH INHIBITORS,
RP   AND WD40-LIKE REPEATS.
RX   PubMed=21816279; DOI=10.1016/j.cell.2011.06.025;
RA   von Kleist L., Stahlschmidt W., Bulut H., Gromova K., Puchkov D.,
RA   Robertson M.J., MacGregor K.A., Tomilin N., Pechstein A., Chau N.,
RA   Chircop M., Sakoff J., von Kries J.P., Saenger W., Krausslich H.G.,
RA   Shupliakov O., Robinson P.J., McCluskey A., Haucke V.;
RT   "Role of the clathrin terminal domain in regulating coated pit dynamics
RT   revealed by small molecule inhibition.";
RL   Cell 146:471-484(2011).
RN   [36]
RP   INTERACTION WITH USP2.
RX   PubMed=26756164; DOI=10.1371/journal.pone.0145155;
RA   Pouly D., Chenaux S., Martin V., Babis M., Koch R., Nagoshi E.,
RA   Katanaev V.L., Gachon F., Staub O.;
RT   "USP2-45 is a circadian clock output effector regulating calcium absorption
RT   at the post-translational level.";
RL   PLoS ONE 11:E0145155-E0145155(2016).
RN   [37]
RP   INTERACTION WITH DNAJC6.
RX   PubMed=29735704; DOI=10.1073/pnas.1717590115;
RA   Nguyen M., Krainc D.;
RT   "LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic
RT   neurons from patients with Parkinson's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 115:5576-5581(2018).
RN   [38]
RP   INVOLVEMENT IN MRD56.
RX   PubMed=26822784; DOI=10.1002/ajmg.a.37506;
RA   DeMari J., Mroske C., Tang S., Nimeh J., Miller R., Lebel R.R.;
RT   "CLTC as a clinically novel gene associated with multiple malformations and
RT   developmental delay.";
RL   Am. J. Med. Genet. A 170A:958-966(2016).
RN   [39]
RP   INVOLVEMENT IN MRD56, AND VARIANTS MRD56 554-MET--TYR-556 DEL; LEU-890;
RP   PRO-1047; ARG-1108; 1199-GLN--MET-1675 DEL; ASP-1207 DEL;
RP   1555-GLN--MET-1675 DEL AND 1556-TRP--MET-1675 DEL.
RX   PubMed=29100083; DOI=10.1016/j.ajhg.2017.09.008;
RG   Deciphering Developmental Disorders Study;
RA   Hamdan F.F., Myers C.T., Cossette P., Lemay P., Spiegelman D.,
RA   Laporte A.D., Nassif C., Diallo O., Monlong J., Cadieux-Dion M.,
RA   Dobrzeniecka S., Meloche C., Retterer K., Cho M.T., Rosenfeld J.A., Bi W.,
RA   Massicotte C., Miguet M., Brunga L., Regan B.M., Mo K., Tam C.,
RA   Schneider A., Hollingsworth G., FitzPatrick D.R., Donaldson A., Canham N.,
RA   Blair E., Kerr B., Fry A.E., Thomas R.H., Shelagh J., Hurst J.A.,
RA   Brittain H., Blyth M., Lebel R.R., Gerkes E.H., Davis-Keppen L., Stein Q.,
RA   Chung W.K., Dorison S.J., Benke P.J., Fassi E., Corsten-Janssen N.,
RA   Kamsteeg E.J., Mau-Them F.T., Bruel A.L., Verloes A., Ounap K.,
RA   Wojcik M.H., Albert D.V.F., Venkateswaran S., Ware T., Jones D., Liu Y.C.,
RA   Mohammad S.S., Bizargity P., Bacino C.A., Leuzzi V., Martinelli S.,
RA   Dallapiccola B., Tartaglia M., Blumkin L., Wierenga K.J., Purcarin G.,
RA   O'Byrne J.J., Stockler S., Lehman A., Keren B., Nougues M.C., Mignot C.,
RA   Auvin S., Nava C., Hiatt S.M., Bebin M., Shao Y., Scaglia F., Lalani S.R.,
RA   Frye R.E., Jarjour I.T., Jacques S., Boucher R.M., Riou E., Srour M.,
RA   Carmant L., Lortie A., Major P., Diadori P., Dubeau F., D'Anjou G.,
RA   Bourque G., Berkovic S.F., Sadleir L.G., Campeau P.M., Kibar Z.,
RA   Lafreniere R.G., Girard S.L., Mercimek-Mahmutoglu S., Boelman C.,
RA   Rouleau G.A., Scheffer I.E., Mefford H.C., Andrade D.M., Rossignol E.,
RA   Minassian B.A., Michaud J.L.;
RT   "High rate of recurrent de novo mutations in developmental and epileptic
RT   encephalopathies.";
RL   Am. J. Hum. Genet. 101:664-685(2017).
CC   -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of
CC       coated pits and vesicles. Two different adapter protein complexes link
CC       the clathrin lattice either to the plasma membrane or to the trans-
CC       Golgi network. Acts as a component of the TACC3/ch-TOG/clathrin complex
CC       proposed to contribute to stabilization of kinetochore fibers of the
CC       mitotic spindle by acting as inter-microtubule bridge (PubMed:15858577,
CC       PubMed:16968737, PubMed:21297582). The TACC3/ch-TOG/clathrin complex is
CC       required for the maintenance of kinetochore fiber tension
CC       (PubMed:23532825). Plays a role in early autophagosome formation
CC       (PubMed:20639872). Interaction with DNAJC6 mediates the recruitment of
CC       HSPA8 to the clathrin lattice and creates local destabilization of the
CC       lattice promoting uncoating (By similarity).
CC       {ECO:0000250|UniProtKB:P49951, ECO:0000269|PubMed:15858577,
CC       ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:20639872,
CC       ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}.
CC   -!- SUBUNIT: Clathrin triskelions, composed of 3 heavy chains and 3 light
CC       chains, are the basic subunits of the clathrin coat (PubMed:16968737).
CC       In the presence of light chains, hub assembly is influenced by both the
CC       pH and the concentration of calcium. Interacts with HIP1
CC       (PubMed:11532990). Interacts with DENND1A, DENND1B and DENND1C (By
CC       similarity). May interact with OCRL (By similarity). Interacts with
CC       ERBB2 (PubMed:16314522). Interacts with FKBP6 (PubMed:18529014).
CC       Interacts with CKAP5 and TACC3 forming the TACC3/ch-TOG/clathrin
CC       complex located at spindle inter-microtubules bridges; the complex
CC       implicates clathrin triskelions; TACC3 and CLTC are proposed to form a
CC       composite microtubule interaction surface (PubMed:21297582). Interacts
CC       with ATG16L1 (via N-terminus) (PubMed:20639872). Interacts with RFTN1;
CC       the interaction occurs in response to pathogens (PubMed:21266579,
CC       PubMed:27022195). Interacts with USP2 isoform 4 (PubMed:26756164).
CC       Interacts with TMEM106B (via N-terminus) (PubMed:25066864). Interacts
CC       with DNAJC6; this interaction produces a local change in heavy-chain
CC       contacts, creating a detectable global distortion of the clathrin coat
CC       and leads to the recruitment of HSPA8 (PubMed:29735704).
CC       {ECO:0000250|UniProtKB:P49951, ECO:0000250|UniProtKB:Q68FD5,
CC       ECO:0000269|PubMed:11532990, ECO:0000269|PubMed:16314522,
CC       ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:18529014,
CC       ECO:0000269|PubMed:20639872, ECO:0000269|PubMed:21266579,
CC       ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:25066864,
CC       ECO:0000269|PubMed:26756164, ECO:0000269|PubMed:27022195,
CC       ECO:0000269|PubMed:29735704}.
CC   -!- INTERACTION:
CC       Q00610; P32121: ARRB2; NbExp=6; IntAct=EBI-354967, EBI-714559;
CC       Q00610; P09496: CLTA; NbExp=4; IntAct=EBI-354967, EBI-1171169;
CC       Q00610; Q15398: DLGAP5; NbExp=4; IntAct=EBI-354967, EBI-748280;
CC       Q00610; P10242: MYB; NbExp=4; IntAct=EBI-354967, EBI-298355;
CC       Q00610; Q01968: OCRL; NbExp=10; IntAct=EBI-354967, EBI-6148898;
CC       Q00610; Q9H8K7: PAAT; NbExp=5; IntAct=EBI-354967, EBI-714785;
CC       Q00610; Q07912: TNK2; NbExp=2; IntAct=EBI-354967, EBI-603457;
CC       Q00610; O75674: TOM1L1; NbExp=4; IntAct=EBI-354967, EBI-712991;
CC       Q00610; Q306W6; Xeno; NbExp=4; IntAct=EBI-354967, EBI-38815211;
CC       Q00610; Q306W8; Xeno; NbExp=2; IntAct=EBI-354967, EBI-38259300;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:17081065}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17081065}; Cytoplasmic side
CC       {ECO:0000269|PubMed:17081065}. Membrane, coated pit
CC       {ECO:0000269|PubMed:17081065}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17081065}; Cytoplasmic side
CC       {ECO:0000269|PubMed:17081065}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:15858577, ECO:0000269|PubMed:16968737,
CC       ECO:0000269|PubMed:23918938}. Note=Cytoplasmic face of coated pits and
CC       vesicles. Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV. In complex with TACC3 and CKAP5 (forming the
CC       TACC3/ch-TOG/clathrin complex) localized to inter-microtubule bridges
CC       in mitotic spindles. {ECO:0000269|PubMed:25596274}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q00610-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00610-2; Sequence=VSP_011570, VSP_011571;
CC   -!- DOMAIN: The N-terminal seven-bladed beta-propeller is formed by WD40-
CC       like repeats, and projects inward from the polyhedral outer clathrin
CC       coat. It constitutes a major protein-protein interaction node.
CC   -!- DISEASE: Intellectual developmental disorder, autosomal dominant 56
CC       (MRD56) [MIM:617854]: A form of intellectual disability, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period.
CC       {ECO:0000269|PubMed:26822784, ECO:0000269|PubMed:29100083}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the clathrin heavy chain family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA04801.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/360/CLTC";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Clathrin entry;
CC       URL="https://en.wikipedia.org/wiki/Clathrin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D21260; BAA04801.2; ALT_INIT; mRNA.
DR   EMBL; BX640615; CAE45761.1; -; mRNA.
DR   EMBL; CH471109; EAW94396.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94399.1; -; Genomic_DNA.
DR   EMBL; BC051800; AAH51800.1; -; mRNA.
DR   EMBL; BC054489; AAH54489.1; -; mRNA.
DR   EMBL; X55878; CAA39363.1; -; mRNA.
DR   CCDS; CCDS32696.1; -. [Q00610-1]
DR   PIR; A40573; A40573.
DR   RefSeq; NP_004850.1; NM_004859.4. [Q00610-1]
DR   PDB; 2XZG; X-ray; 1.70 A; A=1-364.
DR   PDB; 4G55; X-ray; 1.69 A; A=1-364.
DR   PDB; 6E4L; X-ray; 1.60 A; A=1-364.
DR   PDB; 6QNN; X-ray; 2.03 A; A=1-364.
DR   PDB; 6QNP; X-ray; 2.70 A; A/B/C/D=1-364.
DR   PDB; 7BN1; X-ray; 1.97 A; A/B=1-364.
DR   PDB; 7BN2; X-ray; 1.97 A; AAA/BBB=1-364.
DR   PDB; 7ZX4; X-ray; 2.08 A; A/B=1-364.
DR   PDB; 9C0Y; X-ray; 1.40 A; A=1-364.
DR   PDB; 9C0Z; X-ray; 1.51 A; A=2-364.
DR   PDBsum; 2XZG; -.
DR   PDBsum; 4G55; -.
DR   PDBsum; 6E4L; -.
DR   PDBsum; 6QNN; -.
DR   PDBsum; 6QNP; -.
DR   PDBsum; 7BN1; -.
DR   PDBsum; 7BN2; -.
DR   PDBsum; 7ZX4; -.
DR   PDBsum; 9C0Y; -.
DR   PDBsum; 9C0Z; -.
DR   AlphaFoldDB; Q00610; -.
DR   SMR; Q00610; -.
DR   BioGRID; 107623; 690.
DR   CORUM; Q00610; -.
DR   ELM; Q00610; -.
DR   FunCoup; Q00610; 3315.
DR   IntAct; Q00610; 281.
DR   MINT; Q00610; -.
DR   STRING; 9606.ENSP00000479606; -.
DR   BindingDB; Q00610; -.
DR   ChEMBL; CHEMBL3108634; -.
DR   MoonDB; Q00610; Curated.
DR   TCDB; 8.A.137.1.1; the clathrin (clathrin) family.
DR   GlyGen; Q00610; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q00610; -.
DR   MetOSite; Q00610; -.
DR   PhosphoSitePlus; Q00610; -.
DR   SwissPalm; Q00610; -.
DR   BioMuta; CLTC; -.
DR   DMDM; 1705916; -.
DR   CPTAC; CPTAC-182; -.
DR   CPTAC; CPTAC-183; -.
DR   jPOST; Q00610; -.
DR   MassIVE; Q00610; -.
DR   PaxDb; 9606-ENSP00000479606; -.
DR   PeptideAtlas; Q00610; -.
DR   PRIDE; Q00610; -.
DR   ProteomicsDB; 57862; -. [Q00610-1]
DR   ProteomicsDB; 57863; -. [Q00610-2]
DR   Pumba; Q00610; -.
DR   ABCD; Q00610; 1 sequenced antibody.
DR   Antibodypedia; 4164; 490 antibodies from 40 providers.
DR   DNASU; 1213; -.
DR   Ensembl; ENST00000269122.8; ENSP00000269122.3; ENSG00000141367.14. [Q00610-1]
DR   Ensembl; ENST00000393043.5; ENSP00000376763.1; ENSG00000141367.14. [Q00610-2]
DR   Ensembl; ENST00000700707.1; ENSP00000515147.1; ENSG00000141367.14. [Q00610-1]
DR   GeneID; 1213; -.
DR   KEGG; hsa:1213; -.
DR   MANE-Select; ENST00000269122.8; ENSP00000269122.3; NM_004859.4; NP_004850.1.
DR   UCSC; uc002ixp.4; human. [Q00610-1]
DR   AGR; HGNC:2092; -.
DR   CTD; 1213; -.
DR   DisGeNET; 1213; -.
DR   GeneCards; CLTC; -.
DR   HGNC; HGNC:2092; CLTC.
DR   HPA; ENSG00000141367; Low tissue specificity.
DR   MalaCards; CLTC; -.
DR   MIM; 118955; gene.
DR   MIM; 617854; phenotype.
DR   OpenTargets; ENSG00000141367; -.
DR   Orphanet; 178469; Autosomal dominant non-syndromic intellectual disability.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   Orphanet; 319308; MiT family translocation renal cell carcinoma.
DR   Orphanet; 442835; Non-specific early-onset epileptic encephalopathy.
DR   VEuPathDB; HostDB:ENSG00000141367; -.
DR   eggNOG; KOG0985; Eukaryota.
DR   GeneTree; ENSGT00950000183166; -.
DR   HOGENOM; CLU_002136_0_0_1; -.
DR   InParanoid; Q00610; -.
DR   OrthoDB; 2113814at2759; -.
DR   PAN-GO; Q00610; 7 GO annotations based on evolutionary models.
DR   PhylomeDB; Q00610; -.
DR   PathwayCommons; Q00610; -.
DR   Reactome; R-HSA-168275; Entry of Influenza Virion into Host Cell via Endocytosis.
DR   Reactome; R-HSA-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-HSA-190873; Gap junction degradation.
DR   Reactome; R-HSA-196025; Formation of annular gap junctions.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation. [Q00610-1]
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis. [Q00610-1]
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis. [Q00610-1]
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-HSA-5140745; WNT5A-dependent internalization of FZD2, FZD5 and ROR2.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-HSA-8964038; LDL clearance.
DR   Reactome; R-HSA-9013420; RHOU GTPase cycle.
DR   Reactome; R-HSA-9013424; RHOV GTPase cycle.
DR   Reactome; R-HSA-9700645; ALK mutants bind TKIs.
DR   Reactome; R-HSA-9725370; Signaling by ALK fusions and activated point mutants.
DR   SignaLink; Q00610; -.
DR   SIGNOR; Q00610; -.
DR   BioGRID-ORCS; 1213; 678 hits in 1175 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; CLTC; human.
DR   EvolutionaryTrace; Q00610; -.
DR   GeneWiki; CLTC; -.
DR   GenomeRNAi; 1213; -.
DR   Pharos; Q00610; Tbio.
DR   PRO; PR:Q00610; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q00610; protein.
DR   Bgee; ENSG00000141367; Expressed in pons and 210 other cell types or tissues.
DR   ExpressionAtlas; Q00610; baseline and differential.
DR   GO; GO:0034451; C:centriolar satellite; IDA:HPA.
DR   GO; GO:0030118; C:clathrin coat; IMP:CAFA.
DR   GO; GO:0030132; C:clathrin coat of coated pit; IEA:InterPro.
DR   GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro.
DR   GO; GO:0071439; C:clathrin complex; IDA:FlyBase.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; IBA:GO_Central.
DR   GO; GO:0030669; C:clathrin-coated endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0036020; C:endolysosome membrane; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; IDA:HPA.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:1990498; C:mitotic spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0032051; F:clathrin light chain binding; IPI:FlyBase.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; NAS:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:UniProtKB.
DR   GO; GO:0150093; P:amyloid-beta clearance by transcytosis; IMP:ARUK-UCL.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0048268; P:clathrin coat assembly; IMP:CAFA.
DR   GO; GO:0072318; P:clathrin coat disassembly; ISS:UniProtKB.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IMP:ARUK-UCL.
DR   GO; GO:0006886; P:intracellular protein transport; NAS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:1900126; P:negative regulation of hyaluronan biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IMP:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IMP:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0033572; P:transferrin transport; IMP:BHF-UCL.
DR   FunFam; 1.25.40.10:FF:000001; Clathrin heavy chain; 1.
DR   FunFam; 1.25.40.10:FF:000002; Clathrin heavy chain; 1.
DR   FunFam; 1.25.40.10:FF:000007; Clathrin heavy chain; 1.
DR   FunFam; 1.25.40.10:FF:000095; Clathrin heavy chain; 1.
DR   FunFam; 1.25.40.730:FF:000001; Clathrin heavy chain; 1.
DR   FunFam; 2.130.10.110:FF:000001; Clathrin heavy chain; 1.
DR   Gene3D; 1.25.40.730; -; 1.
DR   Gene3D; 2.130.10.110; Clathrin heavy-chain terminal domain; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 4.
DR   IDEAL; IID00662; -.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR055358; CHCR.
DR   InterPro; IPR000547; Clathrin_H-chain/VPS_repeat.
DR   InterPro; IPR015348; Clathrin_H-chain_linker_core.
DR   InterPro; IPR016025; Clathrin_H-chain_N.
DR   InterPro; IPR022365; Clathrin_H-chain_propeller_rpt.
DR   InterPro; IPR016341; Clathrin_heavy_chain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   PANTHER; PTHR10292:SF7; CLATHRIN HEAVY CHAIN 1; 1.
DR   PANTHER; PTHR10292; CLATHRIN HEAVY CHAIN RELATED; 1.
DR   Pfam; PF00637; Clathrin; 7.
DR   Pfam; PF09268; Clathrin-link; 1.
DR   Pfam; PF13838; Clathrin_H_link; 1.
DR   Pfam; PF01394; Clathrin_propel; 5.
DR   PIRSF; PIRSF002290; Clathrin_H_chain; 1.
DR   SMART; SM00299; CLH; 7.
DR   SUPFAM; SSF48371; ARM repeat; 6.
DR   SUPFAM; SSF50989; Clathrin heavy-chain terminal domain; 1.
DR   PROSITE; PS50236; CHCR; 7.
DR   neXtProt; NX_Q00610; -.
DR   PharmGKB; PA26618; -.
DR   TreeFam; TF300059; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Autophagy; Cell cycle;
KW   Cell division; Coated pit; Cytoplasm; Cytoplasmic vesicle; Cytoskeleton;
KW   Direct protein sequencing; Disease variant; Intellectual disability;
KW   Membrane; Mitosis; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801, ECO:0000269|Ref.7,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378,
FT                   ECO:0007744|PubMed:25944712"
FT   CHAIN           2..1675
FT                   /note="Clathrin heavy chain 1"
FT                   /id="PRO_0000205778"
FT   REPEAT          537..683
FT                   /note="CHCR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          686..828
FT                   /note="CHCR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          833..972
FT                   /note="CHCR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          979..1124
FT                   /note="CHCR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          1128..1269
FT                   /note="CHCR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          1274..1420
FT                   /note="CHCR 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          1423..1566
FT                   /note="CHCR 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REGION          2..479
FT                   /note="Globular terminal domain"
FT   REGION          24..67
FT                   /note="WD40-like repeat 1"
FT   REGION          68..107
FT                   /note="WD40-like repeat 2"
FT   REGION          108..149
FT                   /note="WD40-like repeat 3"
FT   REGION          150..195
FT                   /note="WD40-like repeat 4"
FT   REGION          196..257
FT                   /note="WD40-like repeat 5"
FT   REGION          258..301
FT                   /note="WD40-like repeat 6"
FT   REGION          302..330
FT                   /note="WD40-like repeat 7"
FT   REGION          449..465
FT                   /note="Binding site for the uncoating ATPase, involved in
FT                   lattice disassembly"
FT                   /evidence="ECO:0000255"
FT   REGION          457..507
FT                   /note="Involved in spindle localization and interaction
FT                   with TACC3"
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   REGION          480..523
FT                   /note="Flexible linker"
FT   REGION          524..1675
FT                   /note="Heavy chain arm"
FT   REGION          524..634
FT                   /note="Distal segment"
FT   REGION          639..1675
FT                   /note="Proximal segment"
FT   REGION          1213..1522
FT                   /note="Involved in binding clathrin light chain"
FT                   /evidence="ECO:0000250"
FT   REGION          1550..1675
FT                   /note="Trimerization"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.7, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         105
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         184
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         394
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         634
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         737
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         856
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         899
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1206
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1441
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         1441
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1477
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         1487
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         1501
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         1636..1639
FT                   /note="QPQL -> NLSL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011570"
FT   VAR_SEQ         1640..1675
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011571"
FT   VARIANT         554..556
FT                   /note="Missing (in MRD56; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080721"
FT   VARIANT         890
FT                   /note="P -> L (in MRD56; dbSNP:rs1555606635)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080722"
FT   VARIANT         1047
FT                   /note="L -> P (in MRD56; uncertain significance;
FT                   dbSNP:rs1555607159)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080723"
FT   VARIANT         1108
FT                   /note="W -> R (in MRD56; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080724"
FT   VARIANT         1199..1675
FT                   /note="Missing (in MRD56)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080725"
FT   VARIANT         1207
FT                   /note="Missing (in MRD56; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080726"
FT   VARIANT         1555..1675
FT                   /note="Missing (in MRD56)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080727"
FT   VARIANT         1556..1675
FT                   /note="Missing (in MRD56)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080728"
FT   MUTAGEN         65
FT                   /note="P->N: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         67
FT                   /note="S->G: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         87
FT                   /note="T->A: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         89
FT                   /note="Q->A: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         96
FT                   /note="K->E: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         98
FT                   /note="K->E: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         444
FT                   /note="R->E: Disrupts spindle localization; when associated
FT                   with E-445, E-500 E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         445
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-500, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         480..484
FT                   /note="LRANV->ERGQC: Disrupts spindle localization and
FT                   interaction with TACC3."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         481
FT                   /note="R->E: Disrupts spindle localization; when associated
FT                   with E-487, E-500, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         487
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-500, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         500
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-445, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         500
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-487, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         506
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-445, E-500 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         506
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-487, E-500 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         507
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-445, E-500 and E-506."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         507
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-487, E-500 and E-506."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   CONFLICT        560
FT                   /note="Q -> R (in Ref. 5; CAA39363)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        817
FT                   /note="G -> V (in Ref. 5; CAA39363)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        923
FT                   /note="R -> H (in Ref. 2; CAE45761)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1563
FT                   /note="R -> G (in Ref. 2; CAE45761)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1652
FT                   /note="Q -> R (in Ref. 2; CAE45761)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..14
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   HELIX           15..18
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   HELIX           22..24
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   TURN            27..29
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          30..34
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          37..44
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          47..54
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          69..73
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          75..84
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          87..92
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   TURN            93..96
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          97..103
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          108..113
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          115..135
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          139..143
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   HELIX           146..148
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          152..158
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          164..173
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          176..185
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   TURN            186..189
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          190..194
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          197..204
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          213..222
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          225..232
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          246..249
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   HELIX           254..256
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          261..267
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   TURN            268..271
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          272..277
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          280..286
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   TURN            287..289
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          292..297
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          303..309
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   TURN            310..313
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          314..319
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   STRAND          323..329
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   TURN            331..333
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   HELIX           334..340
FT                   /evidence="ECO:0007829|PDB:6E4L"
FT   HELIX           345..354
FT                   /evidence="ECO:0007829|PDB:6E4L"
SQ   SEQUENCE   1675 AA;  191615 MW;  6C4F2D54950079E2 CRC64;
     MAQILPIRFQ EHLQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV VIIDMNDPSN
     PIRRPISADS AIMNPASKVI ALKAGKTLQI FNIEMKSKMK AHTMTDDVTF WKWISLNTVA
     LVTDNAVYHW SMEGESQPVK MFDRHSSLAG CQIINYRTDA KQKWLLLTGI SAQQNRVVGA
     MQLYSVDRKV SQPIEGHAAS FAQFKMEGNA EESTLFCFAV RGQAGGKLHI IEVGTPPTGN
     QPFPKKAVDV FFPPEAQNDF PVAMQISEKH DVVFLITKYG YIHLYDLETG TCIYMNRISG
     ETIFVTAPHE ATAGIIGVNR KGQVLSVCVE EENIIPYITN VLQNPDLALR MAVRNNLAGA
     EELFARKFNA LFAQGNYSEA AKVAANAPKG ILRTPDTIRR FQSVPAQPGQ TSPLLQYFGI
     LLDQGQLNKY ESLELCRPVL QQGRKQLLEK WLKEDKLECS EELGDLVKSV DPTLALSVYL
     RANVPNKVIQ CFAETGQVQK IVLYAKKVGY TPDWIFLLRN VMRISPDQGQ QFAQMLVQDE
     EPLADITQIV DVFMEYNLIQ QCTAFLLDAL KNNRPSEGPL QTRLLEMNLM HAPQVADAIL
     GNQMFTHYDR AHIAQLCEKA GLLQRALEHF TDLYDIKRAV VHTHLLNPEW LVNYFGSLSV
     EDSLECLRAM LSANIRQNLQ ICVQVASKYH EQLSTQSLIE LFESFKSFEG LFYFLGSIVN
     FSQDPDVHFK YIQAACKTGQ IKEVERICRE SNCYDPERVK NFLKEAKLTD QLPLIIVCDR
     FDFVHDLVLY LYRNNLQKYI EIYVQKVNPS RLPVVIGGLL DVDCSEDVIK NLILVVRGQF
     STDELVAEVE KRNRLKLLLP WLEARIHEGC EEPATHNALA KIYIDSNNNP ERFLRENPYY
     DSRVVGKYCE KRDPHLACVA YERGQCDLEL INVCNENSLF KSLSRYLVRR KDPELWGSVL
     LESNPYRRPL IDQVVQTALS ETQDPEEVSV TVKAFMTADL PNELIELLEK IVLDNSVFSE
     HRNLQNLLIL TAIKADRTRV MEYINRLDNY DAPDIANIAI SNELFEEAFA IFRKFDVNTS
     AVQVLIEHIG NLDRAYEFAE RCNEPAVWSQ LAKAQLQKGM VKEAIDSYIK ADDPSSYMEV
     VQAANTSGNW EELVKYLQMA RKKARESYVE TELIFALAKT NRLAELEEFI NGPNNAHIQQ
     VGDRCYDEKM YDAAKLLYNN VSNFGRLAST LVHLGEYQAA VDGARKANST RTWKEVCFAC
     VDGKEFRLAQ MCGLHIVVHA DELEELINYY QDRGYFEELI TMLEAALGLE RAHMGMFTEL
     AILYSKFKPQ KMREHLELFW SRVNIPKVLR AAEQAHLWAE LVFLYDKYEE YDNAIITMMN
     HPTDAWKEGQ FKDIITKVAN VELYYRAIQF YLEFKPLLLN DLLMVLSPRL DHTRAVNYFS
     KVKQLPLVKP YLRSVQNHNN KSVNESLNNL FITEEDYQAL RTSIDAYDNF DNISLAQRLE
     KHELIEFRRI AAYLFKGNNR WKQSVELCKK DSLYKDAMQY ASESKDTELA EELLQWFLQE
     EKRECFGACL FTCYDLLRPD VVLETAWRHN IMDFAMPYFI QVMKEYLTKV DKLDASESLR
     KEEEQATETQ PIVYGQPQLM LTAGPSVAVP PQAPFGYGYT APPYGQPQPG FGYSM
//
